VulnerabilityModified
CVE-2023-32662
Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.
MEDIUM 6.7EPSS 0.23%
Does this matter?
Lower severity and a low EPSS score (0.23%). Track it; it rarely justifies an emergency change on its own.
Description
Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.
- CVSS 3.1
- 6.7 MEDIUMCVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
- EPSS
- 0.23% probability · 14th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-285
- Affected
- intel/battery life diagnostic tool
- Source
- secure@intel.com
References
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.